Immuron
IMRN
7 hedge funds and large institutions have $1.4M invested in Immuron in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
40% more funds holding
Funds holding: 5 → 7 (+2)
15% more capital invested
Capital invested by funds: $1.22M → $1.4M (+$185K)
0.02% more ownership
Funds ownership: 0.08% → 0.1% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$276K |
| 2 |
Renaissance Technologies
New York
|
+$16K |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
+$13.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13.3K |
IMRN Hedge Fund Activity: Q1 2021 in Review
7 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q1 2021, worth a combined $1.4M — up 15% from $1.22M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IMRN positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $276K. The largest seller was UBS Group, cutting an estimated $13.3K.
- 7 institutional investors held Immuron (IMRN) as of Q1 2021, up from 5 in Q4 2020.
- Funds reported $1.4M of Immuron stock for Q1 2021, up 15% quarter-over-quarter.
- 2 funds opened new Immuron positions in Q1 2021 and 0 closed out, a net change of +2 holders.
- The largest Immuron buyer in Q1 2021 was Morgan Stanley, an estimated $276K added.
- The largest Immuron seller in Q1 2021 was UBS Group, an estimated $13.3K sold.
Based on aggregated 13F filings for Q1 2021.